Literature DB >> 20216396

Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study.

Catherine Paugam-Burtz1, Miguel Albuquerque, Gabriel Baron, Frederic Bert, Hélène Voitot, Didier Delefosse, Federica Dondero, Daniele Sommacale, Claire Francoz, Nadine Hanna, Jacques Belghiti, Philippe Ravaud, Pierre Bedossa, Jean Mantz, Valérie Paradis.   

Abstract

BACKGROUND: While outcome continuously improves after liver transplantation, sepsis remains the leading cause of early postoperative mortality. Diagnosis of infections remains particularly difficult in these patients. This study used plasma profiling coupling Proteinchip array with surface-enhanced laser desorption ionization time-of-fly mass spectrometry to search for biomarkers of postoperative sepsis in patients who underwent liver transplantation.
METHODS: Diagnosis of sepsis at day 5 relied on widely accepted clinical signs and positive culture of microbiologic samples. Profiles of day 5 plasma were obtained from SELDI-TOF CM10 chip (BioRad, Marnes-la-Coquette, France) analysis. Mean peak intensity of proteins was compared between septic and nonseptic plasma by U test followed by analysis of the area under the receiver-operating characteristic for the significant peaks. Diagnostic performance of significant proteins was established in a derivation set and in a validation set.
RESULTS: In the derivation set of 31 patients with and 30 without infection, 23 plasma protein peaks were differentially expressed between patients with and without sepsis. Combination of five peaks allowed sepsis diagnosis with a positive likelihood ratio of 12.5 and a C-statistics of 0.72, 95% CI 0.57-0.85. In the validation set of 31 patients with infection and 34 without infection, the five peaks were differentially expressed as well and allowed day 5 sepsis diagnosis with a positive likelihood ratio of 5.1 and C-statistics of 0.74 (0.58-0.85).
CONCLUSION: A combination of five plasma protein peaks may provide material for useful diagnostic biomarkers of postoperative sepsis in patients undergoing liver transplantation. However, these proteins remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20216396     DOI: 10.1097/ALN.0b013e3181d049f0

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.

Authors:  Alexander Choukèr; Akio Ohta; André Martignoni; Dmitriy Lukashev; Lefteris C Zacharia; Edwin K Jackson; Jürgen Schnermann; Jerrold M Ward; Ines Kaufmann; Brenda Klaunberg; Michail V Sitkovsky; Manfred Thiel
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

2.  Prognostic Value of Procalcitonin, CRP, Serum Amyloid A, Lactate and IL-6 Markers in Liver Transplant Patients Admitted to ED with Suspected Infection.

Authors:  Ali Gür; Hakan Oguzturk; Adem Köse; M Gökhan Turtay; Veysel Ersan; Yaşar Bayindir; Volkan Ince; Sukru Gurbuz; Neslihan Yucel
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

Review 3.  Sepsis biomarkers: an omics perspective.

Authors:  Xiao Liu; Hui Ren; Daizhi Peng
Journal:  Front Med       Date:  2014-01-30       Impact factor: 4.592

Review 4.  Bench-to-bedside review: future novel diagnostics for sepsis - a systems biology approach.

Authors:  Simon Skibsted; Manoj K Bhasin; William C Aird; Nathan I Shapiro
Journal:  Crit Care       Date:  2013-10-04       Impact factor: 9.097

5.  Bioinformatical Analysis of Organ-Related (Heart, Brain, Liver, and Kidney) and Serum Proteomic Data to Identify Protein Regulation Patterns and Potential Sepsis Biomarkers.

Authors:  Andreas Hohn; Ivan Iovino; Fabrizio Cirillo; Hendrik Drinhaus; Kathrin Kleinbrahm; Lennert Boehm; Edoardo De Robertis; Jochen Hinkelbein
Journal:  Biomed Res Int       Date:  2018-03-21       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.